1. Home
  2. PSQH vs IMRX Comparison

PSQH vs IMRX Comparison

Compare PSQH & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PSQ Holdings Inc.

PSQH

PSQ Holdings Inc.

HOLD

Current Price

$1.29

Market Cap

62.4M

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$5.74

Market Cap

373.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSQH
IMRX
Founded
2021
2008
Country
United States
United States
Employees
N/A
54
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.4M
373.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PSQH
IMRX
Price
$1.29
$5.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$6.00
$17.20
AVG Volume (30 Days)
615.7K
835.3K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,534,522.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$48.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
196.08
N/A
52 Week Low
$1.23
$1.10
52 Week High
$5.18
$10.08

Technical Indicators

Market Signals
Indicator
PSQH
IMRX
Relative Strength Index (RSI) 36.15 33.85
Support Level $1.35 $5.93
Resistance Level $1.44 $6.54
Average True Range (ATR) 0.09 0.38
MACD 0.02 -0.15
Stochastic Oscillator 23.08 4.44

Price Performance

Historical Comparison
PSQH
IMRX

About PSQH PSQ Holdings Inc.

PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: